Global Clinical Trials: Latin America - The Promised Land

Latin America holds much potential for the conduct of clinical trials. However, an awareness of issues and proper preparation can overcome any challenges that arise, as well as ensuring maximum effectiveness in research efforts.

The size of the subcontinent and the potential for this area to significantly augment recruitment and, as a result, reduce trial timelines, should call to sponsors to take a closer look. Sponsors need to examine how to effectively utilise this relatively untapped resource to achieve these objectives.

This article in the Autumn 2011 edition of the journal European Pharmaceutical Contractor (EPC), by Paul Braconnier, Laura Garcia and Patricia Goddard of the Harrison Clinical Research Group, will examine the benefits of conducting clinical trials in Latin America, as well as discuss the potential challenges that can arise and what can be done to effectively manage these, particularly looking at Argentina and Mexico, although the majority of the points raised will also apply to many of the countries in Latin America.

Read moreEuropean Pharmaceutical Contractor (EPC),
Autumn 2011